CORC

在结果中检索

CORC

浏览/检索结果: 共88条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Size-Independent Fast Ion Intercalation in Two-Dimensional Titania Nanosheets for Alkali-Metal-Ion Batteries 期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 卷号: 58, 期号: 26, 页码: 8740-8745
作者:  Yang, Jinlin;  Xiao, Xu;  Gong, Wenbin;  Zhao, Liang;  Li, Guohui
收藏  |  浏览/下载：55/0  |  提交时间：2021/02/02
Size-Independent Fast Ion Intercalation in Two-Dimensional Titania Nanosheets for Alkali-Metal-Ion Batteries 期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 卷号: 58, 期号: 26, 页码: 8740-8745
作者:  Yang, Jinlin;  Xiao, Xu;  Gong, Wenbin;  Zhao, Liang;  Li, Guohui
收藏  |  浏览/下载：59/0  |  提交时间：2021/02/02
一种钢筋自动套丝系统 专利
申请日期: 2019-04-05, 公开日期: 2019-04-05
作者:  乔明;  胡立志;  张兴宏;  于波;  余亚冰
收藏  |  浏览/下载：0/0  |  提交时间：2020/11/11
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Monodispersed dendritic mesoporous silica/carbon nanospheres with enhanced active site accessibility for selective adsorptive desulfurization 期刊论文
JOURNAL OF MATERIALS SCIENCE, 2019, 卷号: 54, 页码: 8148-8162
作者:  Liu, Cong;  Yuan, Pei;  Duan, Aijun;  Mei, Jinlin;  Zheng, Peng
收藏  |  浏览/下载：15/0  |  提交时间：2019/11/21
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace